Literature DB >> 20166945

The medicinal chemistry of 5-HT6 receptor ligands with a focus on arylsulfonyltryptamine analogs.

Richard A Glennon1, Uma Siripurapu, Bryan L Roth, Renata Kolanos, Mikhail L Bondarev, Donald Sikazwe, Mase Lee, Małgorzata Dukat.   

Abstract

Arylsulfonyl analogs of aminopyrimidines (e.g. Ro 04-6790; 2), aminopyridines (e.g. Ro 63-0563; 3), 1-phenylpiperazines (e.g. SB-271046; 4), and tryptamines (e.g. MS-245; 5) were described as the first examples of selective 5-HT(6) receptor antagonists only ten years ago. Today, hundreds of compounds of seemingly diverse structure have been reported. The early antagonists featured an arylsulfonyl group leading to the wide notspread assumption that an arylsulfonyl moiety might be critical for binding and antagonist action. With respect to the arylsulfonyltryptamines, it seems that neither the "arylsulfonyl" nor the "tryptamine" portion of these compounds is essential for binding or for antagonist action, and some such derivatives even display agonist action. The present review describes many of the currently available 5-HT(6) receptor ligands and, unlike prior reviews, provides a narrative of the thinking (where possible) that led to their design, synthesis, and evaluation. The arylsulfonyltryptamines are also used as the structural basis of attempts to relate various structure-types to one another to afford a better understanding of the overall structural requirements for 5-HT(6) receptor binding.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20166945      PMCID: PMC5839515          DOI: 10.2174/156802610791111542

Source DB:  PubMed          Journal:  Curr Top Med Chem        ISSN: 1568-0266            Impact factor:   3.295


  48 in total

Review 1.  Medicinal chemistry strategies to 5-HT(6) receptor ligands as potential cognitive enhancers and antiobesity agents.

Authors:  Jörg Holenz; Petrus J Pauwels; José Luis Díaz; Ramon Mercè; Xavier Codony; Helmut Buschmann
Journal:  Drug Discov Today       Date:  2006-04       Impact factor: 7.851

2.  Studies towards the identification of a new generation of atypical antipsychotic agents.

Authors:  Vincenzo Garzya; Ian T Forbes; Andrew D Gribble; Mike S Hadley; Andrew P Lightfoot; Andrew H Payne; Alexander B Smith; Sara E Douglas; David G Cooper; Ian G Stansfield; Malcom Meeson; Emma E Dodds; Declan N C Jones; Martyn Wood; Charlie Reavill; Carol A Scorer; Angela Worby; Graham Riley; Peter Eddershaw; Chris Ioannou; Daniele Donati; Jim J Hagan; Emiliangelo A Ratti
Journal:  Bioorg Med Chem Lett       Date:  2006-10-19       Impact factor: 2.823

3.  A regiospecific synthesis of a series of 1-sulfonyl azepinoindoles as potent 5-HT6 ligands.

Authors:  Kevin G Liu; Jennifer R Lo; Thomas A Comery; Guo Ming Zhang; Jean Y Zhang; Dianne M Kowal; Deborah L Smith; Li Di; Edward H Kerns; Lee E Schechter; Albert J Robichaud
Journal:  Bioorg Med Chem Lett       Date:  2008-06-13       Impact factor: 2.823

4.  N-Arylsulfonylindole derivatives as serotonin 5-HT(6) receptor ligands.

Authors:  M G Russell; R J Baker; L Barden; M S Beer; L Bristow; H B Broughton; M Knowles; G McAllister; S Patel; J L Castro
Journal:  J Med Chem       Date:  2001-11-08       Impact factor: 7.446

5.  Further studies on the binding of N1-substituted tryptamines at h5-HT6 receptors.

Authors:  Abner Nyandege; Renata Kolanos; Bryan L Roth; Richard A Glennon
Journal:  Bioorg Med Chem Lett       Date:  2007-01-04       Impact factor: 2.823

6.  CoMFA and CoMSIA 3D QSAR analysis on N1-arylsulfonylindole compounds as 5-HT6 antagonists.

Authors:  Munikumar Reddy Doddareddy; Yong Seo Cho; Hun Yeong Koh; Ae Nim Pae
Journal:  Bioorg Med Chem       Date:  2004-08-01       Impact factor: 3.641

7.  1,2,3,4-tetrahydrocarbazoles as 5-HT6 serotonin receptor ligands.

Authors:  Jean Chang-Fong; Jagadeesh B Rangisetty; Małgorzata Dukat; Vincent Setola; Thomas Raffay; Bryan Roth; Richard A Glennon
Journal:  Bioorg Med Chem Lett       Date:  2004-04-19       Impact factor: 2.823

8.  Indene-based scaffolds. Design and synthesis of novel serotonin 5-HT6 receptor ligands.

Authors:  Ermitas Alcalde; Neus Mesquida; Jordi Frigola; Sara López-Pérez; Ramon Mercè
Journal:  Org Biomol Chem       Date:  2008-08-11       Impact factor: 3.876

9.  Indene-based scaffolds. 2. An indole-indene switch: discovery of novel indenylsulfonamides as 5-HT6 serotonin receptor agonists.

Authors:  Ermitas Alcalde; Neus Mesquida; Sara López-Pérez; Jordi Frigola; Ramon Mercè
Journal:  J Med Chem       Date:  2009-02-12       Impact factor: 7.446

10.  N1-benzenesulfonylgramine and N1-benzenesulfonylskatole: novel 5-HT6 receptor ligand templates.

Authors:  Manik R Pullagurla; Małgorzata Dukat; Vincent Setola; Bryan Roth; Richard A Glennon
Journal:  Bioorg Med Chem Lett       Date:  2003-10-06       Impact factor: 2.823

View more
  5 in total

1.  N1-Azinylsulfonyl-1H-indoles: 5-HT6 Receptor Antagonists with Procognitive and Antidepressant-Like Properties.

Authors:  Paweł Zajdel; Krzysztof Marciniec; Grzegorz Satała; Vittorio Canale; Tomasz Kos; Anna Partyka; Magdalena Jastrzębska-Więsek; Anna Wesołowska; Agnieszka Basińska-Ziobroń; Jacek Wójcikowski; Władysława A Daniel; Andrzej J Bojarski; Piotr Popik
Journal:  ACS Med Chem Lett       Date:  2016-04-07       Impact factor: 4.345

2.  Synthesis, pharmacological evaluations, and molecular docking studies on a new 1,3,4,11b-tetrahydro-1H-fluoreno[9,1-cd]azepine framework: Rigidification of D1 receptor selective 1-phenylbenzazepines and discovery of a new 5-HT6 receptor scaffold.

Authors:  Rajan Giri; Ian Alberts; Wayne W Harding
Journal:  Chem Biol Drug Des       Date:  2020-04-22       Impact factor: 2.817

3.  The 2014 Philip S. Portoghese Medicinal Chemistry Lectureship: The "Phenylalkylaminome" with a Focus on Selected Drugs of Abuse.

Authors:  Richard A Glennon
Journal:  J Med Chem       Date:  2017-03-15       Impact factor: 7.446

Review 4.  Role of serotonin in Alzheimer's disease: a new therapeutic target?

Authors:  Werner J Geldenhuys; Cornelis J Van der Schyf
Journal:  CNS Drugs       Date:  2011-09-01       Impact factor: 5.749

Review 5.  Crosstalk Between Intestinal Serotonergic System and Pattern Recognition Receptors on the Microbiota-Gut-Brain Axis.

Authors:  Elena Layunta; Berta Buey; Jose Emilio Mesonero; Eva Latorre
Journal:  Front Endocrinol (Lausanne)       Date:  2021-11-08       Impact factor: 5.555

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.